Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Sarah Grillo/Axios

It may soon be time for the U.S. to take an unprecedented step and waive the costs of treatment for the new coronavirus, for everyone.

Where it stands: Insurers have already waived the cost of testing for many patients. But if hospitals are deluged with coronavirus cases, as expected, it may also be time to look at the substantially higher cost of treatment.

By the numbers: The average hospitalization for COVID-19 will likely cost more than $20,000, and patients will be on the hook for an average of about $1,300 of that total.

  • Those estimates are conservative. They’re based on an analysis of the cost to treat pneumonia, among people with employer-based insurance.

Not everyone who contracts the coronavirus will require hospitalization; many will be able to recover at home. But those who do require more intensive treatment will be at risk for big hospital bills — which could also scare people away from getting treated or even tested.

  • Almost 6 million uninsured people are at high risk for a serious illness related to COVID-19; they would likely experience the greatest economic hardship.
  • Many people will be shouldering these costs at the same time they’ve been laid off, had their hours cut or are experiencing other economic shocks from the epidemic.

Between the lines: Insurers could face significant challenges if they had to absorb these costs, so some federal help might be warranted. And any waiver on patients’ cost-sharing could be temporary — perhaps expiring once the national emergency declaration is lifted.

Where it stands: This is another part of the coronavirus response in which states are leading the way.

  • Massachusetts and New Mexico have waived treatment cost-sharing for privately insured patients who are not employed by self-insured companies. (Those plans are regulated differently.)

The bottom line: This virus won’t be here forever, but while it’s here, it will be saddling people with big hospital bills exactly the time when they are the most medically and economically fragile. The government could ease that burden by waiving patients’ share of the cost for coronavirus treatment.

Editor's note: This column has been corrected to reflect that one of the two states that waived treatment costs is Massachusetts (not Florida).

Go deeper

Updated 1 hour ago - Politics & Policy

National Guard chief: Pentagon's "unusual" Jan. 6 restrictions led to 3-hour delay

William Walker, commanding general of the D.C. National Guard, testified Wednesday that a three-hour delay in approval for National Guard assistance during the Jan. 6 Capitol attack was exacerbated by "unusual" restrictions on his authorities by Pentagon leadership.

Why it matters: Walker testified that if Army Secretary Ryan McCarthy had not prohibited him in a Jan. 5 memo from using the National Guard's "Quick Reaction Force" without authorization, he would have "immediately" sent troops to the Capitol after receiving a "frantic call" from then-Capitol Police Chief Steven Sund.

2 hours ago - World

U.S.-Iran nuclear diplomacy is going nowhere fast

Illustration: Annelise Capossela/Axios

Iran's cool response to the Biden administration's push for diplomatic engagement, along with rising tensions in the region, makes clear that salvaging the 2015 nuclear deal may be far more difficult than many had anticipated.

The state of play: Both the U.S. and Iran have entered the diplomatic dance, but it seems to be moving in circles.

Venture capital platform Indie.vc is shutting down

Illustration: Sarah Grillo/Axios

Indie.vc, an effort launched six years ago to invest small amounts in bootstrapped businesses, announced on Tuesday that it’s winding down.

Why it matters: Venture capital, despite being the money of innovation, is rarely innovative itself. Indie.vc was an effort to break out of the tedium, so its failure is de facto disappointing.